Reframing the future: why it's time to move beyond the term 'DCT' in clinical trials
Tracks
Track 2
| Thursday, October 31, 2024 |
| 11:00 AM - 11:45 AM |
| Room 109 |
Details
Explore the limitations and evolving perspectives around the term "Decentralised Clinical Trials" (DCT). Delve into how the term might not fully capture the diverse and integrated approaches emerging in clinical trial design.
Speaker
Dr Liz Dallimore
Chief Executive Officer
Argenica Therapeutics
Chair
